New Feature: See Wall Street analyst ratings directly on Finviz charts for deeper context into price action.

Learn More

Earnings Estimates Rising for Cognex (CGNX): Will It Gain?

By Zacks Equity Research | February 19, 2026, 12:20 PM

Cognex Corporation (CGNX) could be a solid choice for investors given the company's remarkably improving earnings outlook. While the stock has been a strong performer lately, this trend might continue since analysts are still raising their earnings estimates for the company.

The rising trend in estimate revisions, which is a result of growing analyst optimism on the earnings prospects of this company, should get reflected in its stock price. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements. Our stock rating tool -- the Zacks Rank -- has this insight at its core.

The five-grade Zacks Rank system, which ranges from a Zacks Rank #1 (Strong Buy) to a Zacks Rank #5 (Strong Sell), has an impressive externally-audited track record of outperformance, with Zacks #1 Ranked stocks generating an average annual return of +25% since 2008.

For Cognex Corporation, strong agreement among the covering analysts in revising earnings estimates upward has resulted in meaningful improvement in consensus estimates for the next quarter and full year.

The chart below shows the evolution of forward 12-month Zacks Consensus EPS estimate:

12 Month EPS

Current-Quarter Estimate Revisions

The company is expected to earn $0.26 per share for the current quarter, which represents a year-over-year change of +62.5%.

The Zacks Consensus Estimate for Cognex has increased 25% over the last 30 days, as one estimate has gone higher compared to no negative revisions.

Current-Year Estimate Revisions

For the full year, the earnings estimate of $1.20 per share represents a change of +17.7% from the year-ago number.

In terms of estimate revisions, the trend for the current year also appears quite encouraging for Cognex. Over the past month, four estimates have moved higher compared to no negative revisions, helping the consensus estimate increase 8.05%.

Favorable Zacks Rank

The promising estimate revisions have helped Cognex earn a Zacks Rank #1 (Strong Buy). The Zacks Rank is a tried-and-tested rating tool that helps investors effectively harness the power of earnings estimate revisions and make the right investment decision.

You can see the complete list of today's Zacks #1 Rank (Strong Buy) stocks here.

Our research shows that stocks with Zacks Rank #1 (Strong Buy) and 2 (Buy) significantly outperform the S&P 500.

Bottom Line

Cognex shares have added 40.4% over the past four weeks, suggesting that investors are betting on its impressive estimate revisions. So, you may consider adding it to your portfolio right away to benefit from its earnings growth prospects.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report


 
Cognex Corporation (CGNX): Free Stock Analysis Report

This article originally published on Zacks Investment Research (zacks.com).

Zacks Investment Research

Mentioned In This Article

Latest News

Feb-19
Feb-19
Feb-18
Feb-18
Feb-18
Feb-17
Feb-16
Feb-12
Feb-12
Feb-12
Feb-12
Feb-12
Feb-12
Feb-12
Feb-12